
Reta - GLP-3
Reta GLP-3 is a triple agonist targeting GLP-1, GIP, and glucagon receptors, being explored for its powerful metabolic effects, especially in obesity and type 2…
Half-life
Approximately 5–7 days
Delivery
Subcutaneous injection (weekly)
Suggested dosage
Not specified
Usage
Mechanism of action
Benefits (3)
- Substantial weight loss
- Improved glycemic control
- Enhanced metabolic rate
Side effects (3)
- Nausea
- Gastrointestinal discomfort
- Possible increased heart rate

